The invention relates to isolated nucleic acids and rAAV-based compositions, methods and kits useful for treating genetic diseases (e.g., alpha-1 antitrypsin deficiency).
Edits on 22 Jul, 2023
"Remove website redirecting to Patent Public Search front page"